Back to Journals » OncoTargets and Therapy » Volume 14

LncRNA SNHG16 Regulates the Progress of Acute Myeloid Leukemia Through miR183-5p–FOXO1 Axis [Retraction]

Authors Yang R, Ma D, Wu Y, Zhang Y, Zhang L

Received 2 December 2021

Accepted for publication 2 December 2021

Published 7 December 2021 Volume 2021:14 Pages 5421—5422

DOI https://doi.org/10.2147/OTT.S352191



Yang R, Ma D, Wu Y, Zhang Y, Zhang L. Onco Targets Ther. 2020;13:12943–12954.

At the authors request, the Editor and Publisher of OncoTargets and Therapy wish to retract the published article. The authors informed the journal that when attempting to reproduce the induction of THP-1 cells to differentiate into macrophages, it was found the THP-1 cells were still suspended, with few adhering cells and no pseudopodia or other macrophage cell forms. The cells were subsequently collected for flow analysis, and no markers of macrophages could be detected. The authors believe that the cell line used for the original experiments was contaminated. In addition, the authors have informed the journal that they cannot provide the original raw data for the reported study. As a result, the authors have determined the findings of the study are invalid and requested for the article to be retracted.

The authors wish to apologise for this error.

Our decision-making was informed by our policy on publishing ethics and integrity and the COPE guidelines on retraction.

The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as “Retracted”.

This retraction relates to this paper

Creative Commons License © 2021 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.